Alector, Inc. (ALEC): Price and Financial Metrics

Alector, Inc. (ALEC): $6.13

0.05 (+0.82%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add ALEC to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#97 of NR

in industry

ALEC Price/Volume Stats

Current price $6.13 52-week high $9.06
Prev. close $6.08 52-week low $3.66
Day low $5.95 Volume 55,695
Day high $6.13 Avg. volume 694,496
50-day MA $6.28 Dividend yield N/A
200-day MA $6.35 Market Cap 586.94M

ALEC Stock Price Chart Interactive Chart >


Alector, Inc. (ALEC) Company Bio


Alector, Inc. operates as a clinical-stage biopharmaceutical company. It develops therapeutics for the treatment of neurodegenerative diseases including frontotemporal dementia (FTD), Alzheimer's disease, and Parkinson's disease. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA


ALEC Latest News Stream


Event/Time News Detail
Loading, please wait...

ALEC Latest Social Stream


Loading social stream, please wait...

View Full ALEC Social Stream

Latest ALEC News From Around the Web

Below are the latest news stories about ALECTOR INC that investors may wish to consider to help them evaluate ALEC as an investment opportunity.

How The Same Treatments May Work For Multiple Neurodegenerative Diseases

Extensive research on NDDs has uncovered a different treatment pathway that's enabling some biotechnology firms to target more than one NDD with the same drug candidate.

TalkMarkets.com | September 21, 2023

Read More 'ALEC' Stories Here

ALEC Price Returns

1-mo -12.55%
3-mo -23.18%
6-mo -5.40%
1-year -2.85%
3-year -64.09%
5-year -67.25%
YTD -23.18%
2023 -13.54%
2022 -55.30%
2021 36.48%
2020 -12.19%
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!